Literature DB >> 9842865

"Disproportion theory" of the cervical spine and spinal cord in patients with juvenile cervical flexion myelopathy. A study comparing cervical magnetic resonance images with those of normal controls.

M Kohno1, H Takahashi, A Yagishita, H Tanabe.   

Abstract

BACKGROUND: Cervical flexion myelopathy is quite a rare condition affecting mainly adolescent males who present with muscular atrophy of the upper extremities. Its etiology is still unknown, as is the cause of its marked male preponderance. Disproportion of the cervical spine and spinal cord is suspected to be one of the etiological causes, however, this has yet to be confirmed.
METHODS: We performed a comparative study of the cervical magnetic resonance (MR) images of six male patients with juvenile cervical flexion myelopathy and of 34 young, normal controls.
RESULTS: In normal controls, the cervical spines and spinal cords were significantly straighter in tall than in short males and in females than in males. In these patients, the cervical spine and spinal cord shapes were straighter, and the cervical spine length/height and cervical spinal cord length/height ratios were significantly higher than those of the height-matched male group. In the female group, the cervical spine and cervical spinal cord shapes were similar to the patient group; however, the cervical spine length/height and spinal cord length/height ratios as well as the heights were significantly smaller than those of the patients.
CONCLUSIONS: The cervical spinal cords of the patients were considered to be stretched even with the neck in neutral position, reflecting disproportion of the cervical spine and spinal cord. The shorter length of the cervical spine and spinal cord in females was suspected to be one of the reasons for the marked male preponderance.

Entities:  

Mesh:

Year:  1998        PMID: 9842865     DOI: 10.1016/s0090-3019(97)00451-5

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  8 in total

Review 1.  A Portuguese case of Hirayama disease.

Authors:  Mário Correia de Sá; Henrique Costa; Sérgio Castro; Marta Vila Real
Journal:  BMJ Case Rep       Date:  2013-10-28

2.  Severe cervical flexion myelopathy with long tract signs: a case report and a review of literature.

Authors:  Takahito Fujimori; Akiko Tamura; Toshitada Miwa; Motoki Iwasaki; Takenori Oda
Journal:  Spinal Cord Ser Cases       Date:  2017-05-11

3.  Kinematic analysis of the cervical cord and cervical canal by dynamic neck motion.

Authors:  Kenji Endo; Hidekazu Suzuki; Hirosuke Nishimura; Hidetoshi Tanaka; Takaaki Shishido; Kengo Yamamoto
Journal:  Asian Spine J       Date:  2014-12-17

4.  Role of dynamic MRI study in Hirayama disease.

Authors:  Anit Parihar; Navdeep Khurana; Pallavi Aga; Ragini Singh; Ravindra Kumar Garg
Journal:  Ann Indian Acad Neurol       Date:  2011-04       Impact factor: 1.383

5.  Snake-Eyes Appearance on MRI Occurs during the Late Stage of Hirayama Disease and Indicates Poor Prognosis.

Authors:  Haocheng Xu; Minghao Shao; Fan Zhang; Cong Nie; Hongli Wang; Wei Zhu; Xinlei Xia; Xiaosheng Ma; Feizhou Lu; Jianyuan Jiang
Journal:  Biomed Res Int       Date:  2019-01-13       Impact factor: 3.411

Review 6.  Update on the Pathogenesis, Clinical Diagnosis, and Treatment of Hirayama Disease.

Authors:  Hongwei Wang; Ye Tian; Jianwei Wu; Sushan Luo; Chaojun Zheng; Chi Sun; Cong Nie; Xinlei Xia; Xiaosheng Ma; Feizhou Lyu; Jianyuan Jiang; Hongli Wang
Journal:  Front Neurol       Date:  2022-02-01       Impact factor: 4.003

7.  A Korean case of juvenile muscular atrophy of distal upper extremity (Hirayama disease) with dynamic cervical cord compression.

Authors:  Ohyun Kwon; Manho Kim; Kwang-Woo Lee
Journal:  J Korean Med Sci       Date:  2004-10       Impact factor: 2.153

8.  The Quantitative Assessment of Imaging Features for the Study of Hirayama Disease Progression.

Authors:  Minghao Shao; Jun Yin; Feizhou Lu; Chaojun Zheng; Hongli Wang; Jianyuan Jiang
Journal:  Biomed Res Int       Date:  2015-10-19       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.